Results 241 to 250 of about 15,549,143 (355)
ABSTRACT Diabetic retinopathy (DR) is a leading cause of vision impairment in patients diagnosed with Type 2 diabetes mellitus (T2DM). Awareness of risk factors is necessary to reduce or prevent harmful effects of DR such as irreversible vision loss, and to help ensure early treatment.
Yu‐Chi Sung +8 more
wiley +1 more source
Beyond Glycemic Control: Vascular Biologic Effects of Antidiabetic Drugs and Their Cardiovascular Promise. [PDF]
Muir KC, Stone C, Sellke FW.
europepmc +1 more source
ABSTRACT Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus. This study investigated the effects of alogliptin on DCM and its underlying mechanisms. A DCM model was constructed and treated with alogliptin. Downstream targets of alogliptin were screened using bioinformatics analysis.
Li‐Jing Jiao +7 more
wiley +1 more source
Increased HbA1c relative to actual glycemic control in patients treated with sodium-glucose cotransporter 2 inhibitors. [PDF]
Mizutani K +14 more
europepmc +1 more source
Metabolic Dysfunction‐Associated Steatotic Liver Disease After Hepatitis C Virus Cure
ABSTRACT Hepatitis C virus (HCV) infection is an infectious disease carrying a high risk of metabolic disorders. Chronic HCV (CHC) patients can possess extrahepatic manifestations such as diabetes, steatotic liver disease (SLD), and other metabolic alterations.
Chung‐Feng Huang +3 more
wiley +1 more source
Microbubble-enhanced ultrasound stimulation of β-cells improves insulin release and glycemic control in mice. [PDF]
Wu Y +8 more
europepmc +1 more source
Intraoperative Glycemic Control
openaire +2 more sources
Poor glycemic control and microvascular complications: key drivers of depressive symptoms in adults with diabetes. [PDF]
Escamilla-Nuñez C +5 more
europepmc +1 more source

